- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Histone Deacytelase (HDAC) Inhibitor
Total 67867 results
-
Texas A&M UniversityTerminated
-
Technical University of MunichNovartisTerminated
-
Virginia Commonwealth UniversityWithdrawn
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)TerminatedSoft Tissue Sarcoma | Renal Cell Carcinoma | Metastatic DiseaseUnited States
-
Novartis PharmaceuticalsTerminatedLeukemia-Lymphoma, Adult T-Cell | Cutaneous T-Cell LymphomaJapan
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University of Erlangen-Nürnberg Medical SchoolTerminated
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Oncolys BioPharma IncUnknown
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
Shanghai Mental Health CenterStanley Medical Research InstituteWithdrawnCognitive Impairment | Schizophrenic DisorderChina
-
Nathan Kline Institute for Psychiatric ResearchStanley Medical Research InstituteWithdrawnCognitive Function | Schizophrenic DisordersUnited States
-
The Netherlands Cancer InstituteUnknownMelanoma | Skin NeoplasmsNetherlands
-
NCIC Clinical Trials GroupS*BIOCompleted
-
National Institute of Allergy and Infectious Diseases...Recruiting
-
Herlev HospitalOdense University HospitalUnknown
-
University of California, San FranciscoNovartisCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromeUnited States
-
Queen Mary University of LondonChroma TherapeuticsUnknownHepatocellular CarcinomaUnited Kingdom
-
University of California, IrvineAlzheimer's AssociationCompleted
-
Syndax PharmaceuticalsCompletedHealthy Volunteer | Drug InteractionUnited States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Boston Children's Hospital; Brigham and Women's HospitalTerminatedSickle Cell Disease | Sickle Cell AnemiaUnited States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
HitGen Inc.TerminatedMultiple Myeloma | Relapsed and Refractory Multiple MyelomaChina
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
Tulane University Health Sciences CenterNovartis; Board of Regents, State of LouisianaWithdrawnBreast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedMelanoma | Skin CancerUnited States
-
Hospices Civils de LyonCompletedAcute Myeloid LeukemiaFrance
-
Imperial College LondonCompleted
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedThymic Carcinoma | ThymomaUnited States
-
Novartis PharmaceuticalsCompletedCancerUnited States, Switzerland, Sweden
-
Koneti RaoCompletedLymphadenopathy | Hypersplenism | ALPSUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); Parke-DavisCompleted
-
Portland VA Medical CenterNational Cancer Institute (NCI); OHSU Knight Cancer Institute; Oregon State UniversityCompletedProstate Cancer PreventionUnited States
-
University of RochesterJohns Hopkins University; Massachusetts General Hospital; University of California... and other collaboratorsCompletedHuntington's DiseaseUnited States
-
University Hospital, MontpellierPoitiers University HospitalUnknownPatients With Recurrent or Refractory Multiple MyelomaFrance
-
Copenhagen University Hospital at HerlevUnknownPolycythemia Vera | Essential ThrombocythemiaSweden, United Kingdom, Denmark, Netherlands
-
Chong Kun Dang PharmaceuticalUnknownHuntington DiseaseKorea, Republic of
-
ItalfarmacoTerminatedHodgkin's LymphomaItaly
-
Herlev HospitalRoche Pharma AG; Bispebjerg Hospital; Copenhagen University Hospital at Herlev; Onxe...TerminatedNon Small Cell Lung CancerDenmark
-
CancerCare ManitobaThe Leukemia and Lymphoma SocietyTerminatedChronic Lymphocytic LeukemiaCanada
-
Assistance Publique - Hôpitaux de ParisCompletedMyelodysplastic Syndrome (MDS) | Acute Myelogenous Leukaemia (AML)France
-
4SC AGCompletedHodgkin's LymphomaPoland, Czech Republic, Romania
-
ItalfarmacoCompletedMyeloproliferative DiseasesItaly
-
Imperial College LondonMedical Research Council; University of Oxford; Guy's and St Thomas' NHS Foundation... and other collaboratorsCompleted
-
Novartis PharmaceuticalsCompletedNeoplasms | Non-Hodgkin LymphomaUnited States, Netherlands
-
Novartis PharmaceuticalsCompletedLymphoma | Leukemia | Multiple MyelomaUnited States, Germany, Australia
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
University of California, Los AngelesNot yet recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNovartis; Genentech, Inc.CompletedHead and Neck Cancer | Lung CancerUnited States